AU2005231458A1 - Bioactive stents for type II diabetics and methods for use thereof - Google Patents

Bioactive stents for type II diabetics and methods for use thereof Download PDF

Info

Publication number
AU2005231458A1
AU2005231458A1 AU2005231458A AU2005231458A AU2005231458A1 AU 2005231458 A1 AU2005231458 A1 AU 2005231458A1 AU 2005231458 A AU2005231458 A AU 2005231458A AU 2005231458 A AU2005231458 A AU 2005231458A AU 2005231458 A1 AU2005231458 A1 AU 2005231458A1
Authority
AU
Australia
Prior art keywords
stent
polymer
bioligand
biodegradable
bioactive agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005231458A
Other languages
English (en)
Inventor
Kenneth W. Carpenter
Kristen M. Defife
Kathryn A. Grako
William G. Turnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivas LLC
Original Assignee
Medivas LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivas LLC filed Critical Medivas LLC
Publication of AU2005231458A1 publication Critical patent/AU2005231458A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
AU2005231458A 2004-04-05 2005-04-04 Bioactive stents for type II diabetics and methods for use thereof Abandoned AU2005231458A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55993704P 2004-04-05 2004-04-05
US60/559,937 2004-04-05
PCT/US2005/011231 WO2005097186A2 (fr) 2004-04-05 2005-04-04 Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation

Publications (1)

Publication Number Publication Date
AU2005231458A1 true AU2005231458A1 (en) 2005-10-20

Family

ID=35125623

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005231458A Abandoned AU2005231458A1 (en) 2004-04-05 2005-04-04 Bioactive stents for type II diabetics and methods for use thereof

Country Status (6)

Country Link
EP (1) EP1737379A4 (fr)
JP (1) JP2007532185A (fr)
CN (1) CN1984620B (fr)
AU (1) AU2005231458A1 (fr)
CA (1) CA2562018A1 (fr)
WO (1) WO2005097186A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160287708A9 (en) * 2000-03-15 2016-10-06 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
US20060271168A1 (en) * 2002-10-30 2006-11-30 Klaus Kleine Degradable medical device
US20070160622A1 (en) * 2005-12-07 2007-07-12 Medivas, Llc Method for assembling a polymer-biologic delivery composition
EP1699527A1 (fr) 2004-01-02 2006-09-13 Advanced Cardiovascular Systems, Inc. Dispositifs medicaux revetus de lipoproteine a haute densite
US8163269B2 (en) * 2004-04-05 2012-04-24 Carpenter Kenneth W Bioactive stents for type II diabetics and methods for use thereof
EP1933881B1 (fr) 2005-09-22 2019-03-13 Medivas, LLC Compositions polymères solides pour administration et méthodes d'utilisation de celles-ci
US8445007B2 (en) 2005-09-22 2013-05-21 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
JP5196498B2 (ja) * 2006-05-09 2013-05-15 メディバス エルエルシー 生分解性水溶性ポリマー
US7572625B2 (en) * 2006-05-18 2009-08-11 Boston Scientific Scimed, Inc. Medical devices coated with drug carrier macromolecules
WO2008086490A2 (fr) * 2007-01-11 2008-07-17 Robert Lamar Bjork, Jr Endoprothèse coronaire à élution de médicaments multiples pour intervention coronarienne percutanée
JP2010533548A (ja) * 2007-07-17 2010-10-28 メディバス エルエルシー 生体吸収性エラストマー動脈支持装置および使用方法
US20090074831A1 (en) * 2007-09-18 2009-03-19 Robert Falotico LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS
DE102008027095A1 (de) * 2008-06-06 2009-12-17 Siemens Aktiengesellschaft Interventionsvorrichtung zur Sammlung von biologischem Material und Verfahren zu ihrer Herstellung
CN101879102B (zh) * 2009-05-07 2014-07-09 上海微创医疗器械（集团）有限公司 一种凹槽携载式涂层可降解型药物洗脱支架
CN102596278B (zh) * 2009-10-16 2016-06-29 帝斯曼知识产权资产管理有限公司 包含含有双-(α-氨基-二醇-二酯)的聚酯酰胺的涂层
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
EP3159368B1 (fr) 2011-06-23 2024-07-24 DSM IP Assets B.V. Nouveaux copolymères de polyester-amide biodégradables pour l'administration de médicaments
JP2014529997A (ja) * 2011-09-23 2014-11-17 ウニヴェルズィテート シュトゥットガルト 免疫グロブリン結合ドメインを使った血清中半減期延長
US9220759B2 (en) 2012-02-23 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
US9220584B2 (en) 2012-03-30 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a stent and locally administered adjunctive therapy
US20150328374A1 (en) * 2012-12-20 2015-11-19 Dsm Ip Assets B.V. Coating comprising polyesteramide copolymers for drug delivery
CN107106509B (zh) 2014-12-18 2021-11-30 帝斯曼知识产权资产管理有限公司 用于递送酸敏感药物的药物递送系统
EP4069327A1 (fr) * 2019-12-04 2022-10-12 Cortronik GmbH Fibres hybrides polymères gonflables pour un manchon d'une endoprothèse intraluminale

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998052619A2 (fr) * 1997-05-22 1998-11-26 Merck Patent Gmbh Implants recouverts de peptides et procede permettant de les preparer
US7052711B2 (en) * 1999-09-02 2006-05-30 Rice University Nitric oxide-producing hydrogel materials
US6379383B1 (en) * 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
JP2003527439A (ja) * 2000-03-17 2003-09-16 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 抗ｃｄ１８抗体と抗ｃｃｒ２抗体の混合物を用いる狭窄および再狭窄を抑制する方法
JP2001276210A (ja) * 2000-03-28 2001-10-09 Unitika Ltd 抗菌性医療用具及びその製造方法
GB0103668D0 (en) * 2001-02-15 2001-03-28 Biointeractions Ltd Methods and clinical devices for the inhibition or prevention of mammalian cell growth
KR100994543B1 (ko) * 2001-02-16 2010-11-16 아스텔라스세이야쿠 가부시키가이샤 Ｆｋ506을 포함하는 이식편
US20030064053A1 (en) * 2001-08-31 2003-04-03 Shengjiang Liu Multivalent protein conjugate with multiple ligand-binding domains of receptors
CN1303947C (zh) * 2001-12-13 2007-03-14 华东理工大学 药物洗脱性心血管支架及其制备方法
AU2003219718A1 (en) * 2002-02-06 2003-09-02 Orbus Medical Technologies Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
JP2003320036A (ja) * 2002-05-01 2003-11-11 Terumo Corp ステント
EP1603485A4 (fr) * 2003-02-26 2011-03-30 Medivas Llc Endoprotheses vasculaires bioactives et leur mode d'emploi
ES2338560T3 (es) * 2003-05-07 2010-05-10 Advanced Bio Prosthetic Surfaces, Ltd. Implantes metalicos implantables y procedimientos para fabricarlos.
EP1644509B1 (fr) * 2003-07-17 2007-05-02 Bayerische Julius-Maximilians-Universität Würzburg Utilisation de la non-kinase associée a la fak pour fabriquer un médicament destiné a inhiber une sténose et une resténose

Also Published As

Publication number Publication date
JP2007532185A (ja) 2007-11-15
CA2562018A1 (fr) 2005-10-20
EP1737379A4 (fr) 2011-08-17
CN1984620B (zh) 2011-03-30
EP1737379A2 (fr) 2007-01-03
WO2005097186A3 (fr) 2006-09-14
CN1984620A (zh) 2007-06-20
WO2005097186A2 (fr) 2005-10-20

Similar Documents

Publication Publication Date Title
US8163269B2 (en) Bioactive stents for type II diabetics and methods for use thereof
US20110137406A1 (en) Bioactive stents for type ii diabetics and methods for use thereof
AU2005231458A1 (en) Bioactive stents for type II diabetics and methods for use thereof
CA2566713C (fr) Compositions polymeriques de cicatrisation et methodes d'utilisation
US20040170685A1 (en) Bioactive stents and methods for use thereof
US20060188486A1 (en) Wound care polymer compositions and methods for use thereof
US20080288057A1 (en) Bioactive Stents For Type II Diabetics and Methods for Use Thereof
US8652504B2 (en) Solid polymer delivery compositions and methods for use thereof
US7794706B2 (en) Bioactive wound dressings and implantable devices and methods of use
JP2008518666A (ja) 生物活性創傷包帯および移植可能な装置ならびに使用法
Huang Engineering RGD-Modified Liposomes for Targeted Drug Delivery to Activated Platelets

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period